Clinical and Research Progress in the Resection of Gastro-Esophageal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 15 January 2025 | Viewed by 4623
Special Issue Editor
Interests: inflammatory response to intra-operative ventilation and lung surgery; inflammatory response and risk of metastasis; inflammatory mechanisms of treatment-related lung injury; health-related quality of life in esophageal cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to announce a call for submissions to this Special Issue of Cancers, titled "Clinical and Research Progress in the Resection of Gastro-Esophageal cancer". Gastro-esophageal cancers are a source of substantial global morbidity and mortality. Traditionally, non-metastatic cancers are treated with surgical resection, with a possible combination of chemotherapy and radiation therapy. These can also be sources of significant treatment-related toxicities. The resection of gastro-esophageal cancer is associated with some of the highest incidences of morbidity and mortality. The progress related to improving outcomes for patients with gastro-esophageal cancers is dependent on improving the morbidity and mortality associated with resection and surgery.
We encourage the submission of both original research articles and reviews on all aspects of the advances in resection and multi-modal management of gastro-esophageal cancer. All submitted articles will undergo peer review.
Dr. Biniam Kidane
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.